跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.191) 您好!臺灣時間:2026/11/19 18:21
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:鄭佾琪
研究生(外文):I-Chi Cheng
論文名稱:大豆發酵乳對人體之腸胃菌叢及血脂之影響
論文名稱(外文):The Effects of Fermented Soymilk on Human Gut Microflora and Blood Lipids
指導教授:林士祥
指導教授(外文):Shyh-Hsiang Lin
學位類別:碩士
校院名稱:臺北醫學大學
系所名稱:保健營養學系
學門:醫藥衛生學門
學類:營養學類
論文種類:學術論文
論文出版年:2005
畢業學年度:93
語文別:中文
論文頁數:105
中文關鍵詞:大豆發酵乳、腸胃菌叢、血脂、抗氧化
外文關鍵詞:Fermented soymilk、Gut microflora、Blood lipids、Antioxidant
相關次數:
  • 被引用被引用:1
  • 點閱點閱:549
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:2
本研究目的在於探討大豆發酵乳是否有益於人體腸道益生菌生長,及對血脂方面是否具正面功效。第一部份為腸道菌叢研究,篩選無腸胃道方面的疾病及其他健康問題者,年齡介於 21 至 26 歲,性別不拘,共 26 位,以交叉實驗及自體比較方式進行,為期八週,前兩週為排空期,接著兩週為實驗第一期,其後兩週為排空期,接著兩週為實驗第二期。受試者隨機分為兩組:YuSoy 組在第一期飲用大豆發酵乳,第二期飲用未發酵豆漿;而 SoyYu 組第一期飲用未發酵豆漿,第二期飲用大豆發酵乳 (每日攝取 500 mL 飲料)。收集糞便進行微生物活菌數檢測。結果發現飲用大豆發酵乳兩週後,受試者檢體中 Bifidobacterium spp. 及 Lactobacillus spp. 與總厭氧菌之比值,比飲用豆漿後顯著增加 (p < 0.05),Clostridium perfringens 比飲用豆漿後活菌數顯著下降 (p < 0.05)。第二部份為血脂研究,篩選血脂部分偏高之受試者,年齡介於 20 至 55 歲,性別不拘,共 18 位。實驗前兩週為穩定期,接著六週為實驗期,之後兩週為恢復期,實驗期間每天攝取大豆發酵乳 500 mL,於實驗期第零、二、四及六週取得空腹八小時血液進行生化分析,並於實驗期第零及及六週取得在飲用大豆乳酸飲料三小時後之血液進行血漿異黃酮素分析。結果發現,血清低密度脂蛋白膽固醇 (LDL-C) 顯著降低 (p < 0.05),三酸甘油酯濃度 (大於 160 mg/dL 之受試者) 顯著降低 (p < 0.05),高密度脂蛋白膽固醇濃度 (小於 40 mg/dL 之受試者) 顯著增加 (p < 0.05),而總膽固醇無顯著差異。在抗氧化指標方面,血漿總抗氧化力、紅血球中麩胱甘肽濃度與超氧歧化酶活性顯著增加 (p < 0.05),紅血球中觸酶活性無差異性,而血漿脂質過氧化物濃度顯著減少 (p < 0.05),LDL 氧化延遲時間顯著延長 34 min (p < 0.05)。本篇證實飲用大豆發酵乳可增加腸道益生菌及降低有害菌之量,而飲用六週後則可促進體內抗氧化力並降低脂質過氧化物含量,對血脂濃度具有正面功效,因此大豆發酵乳對人體具有益處。
The objective of this study was to investigate the effects of fermented soymilk on human gut microflora and blood lipids. In section one, a cross-over clinical and self-controlled study was performed, in which 26 subjects (21-26 years of age) were randomly divided into two groups. The subjects in the YuSoy group (n = 13) drank fermented soymilk in the first experimental period, while the subjects in the SoyYu group (n = 13) drank soymilk in the first experimental period. Each subject consumed 500 mL of soy drink a day. After two weeks, in the period of fermented soymilk-drinking, the ratios of Bifidobacterium spp. to total anerobic organisms and Lactobacillus spp. to total anerobic organisms significantly increased when compared to those in the soymilk-drinking period (p < 0.05). The population of Clostridium perfringens significantly decreased when compared to those in the soymilk-drinking period (p < 0.05). In section two, a 6-wk clinical and self-controlled study was performed, in which 18 subjects (20-55 years of age) consumed 500 mL of fermented soymilk a day. Blood samples were collected. Blood lipids and antioxidative indexes were measured. After fermented soymilk consumption, the concentration of LDL-cholesterol significantly decreased (p < 0.05), and the concentration of triglycerides in those whose > 160 mg/dL significantly decreased (p < 0.05), and the concentration of HDL-cholesterol in those whose < 40 mg/dL significantly increased (p < 0.05). There was no difference in cholesterol. On the other hand, the concentration of plasma total antioxidant status and glutathione of RBC significantly increased (p < 0.05), while the superoxide dismutase activity significantly increased (p < 0.05). There was no difference in catalase activity of RBC. The thiobarbuturic acid reactive substrance (TBARs) significantly decreased, and the LDL-lag time significantly increased (p < 0.05). These findings indicated that fermented soymilk consumption significantly improved probiotic counts in the human gastrointestinal tract in a two-week period, while the antioxidative condition was improved in a six-week period.
中文摘要 I
Abstract II
目錄 IV
表目錄 VI
圖目錄 VII
附件目錄 VIII
第一章 研究動機 1
第二章 文獻回顧 3
第一部份 大豆簡介 3
第二部份 大豆對心血管疾病之影響 4
第一節 大豆蛋白 4
第二節 大豆異黃酮素 6
第三節 心血管疾病與抗氧化狀態之相關性 8
第三部份 大豆對腸胃道菌相之相關性 14
第一節 腸道菌叢簡介 14
第二節 益生菌、益生質及共生質簡介 15
第三節 發酵飲品及大豆 18
第四節 腸道菌叢與大豆異黃酮素之關係 20
第三章 實驗設計與方法 22
第一部份 人體實驗之實驗架構 22
第二部份 實驗用飲品 23
第一節 實驗用飲品來源 23
第二節 樣品分析項目及方法 23
第三部份 大豆發酵乳及豆漿對腸道菌叢之研究 27
第一節 受試者招募 27
第二節 研究設計 27
第三節 分析項目及方法 28
第四節 統計分析 31
第四部分 大豆發酵乳對血脂影響之研究 32
第一節 受試者招募 32
第二節 研究設計 32
第三節 分析項目及方法 33
第四節 統計分析 38
第四章 結果 39
第一部份 實驗用飲品 39
第一節 實驗用飲料之熱量 39
第二節 大豆發酵乳活菌數 39
第三節 實驗用飲料之異黃酮素含量 39
第四節 Lactobacillus bulgaricus 在人工胃液及膽酸處理之活菌數 40
第二部份 大豆發酵乳對腸道菌叢之研究 44
第一節 受試者基本資料 44
第二節 攝取大豆發酵乳及未發酵豆漿三日飲食紀錄 44
第三節 攝取大豆發酵乳與豆漿之腸道菌相 47
第二部分 大豆發酵乳對血脂影響之研究 55
第一節 受試者基本資料 55
第二節 攝取大豆發酵乳三日飲食紀錄 55
第三節 攝取大豆發酵乳六週後受試者肝腎功能指標及血脂結果 58
第四節 攝取大豆發酵乳後受試者血液抗氧化指標結果 63
第五節 攝取大豆發酵乳後受試者血液異黃酮素含量 63
第五章 討論 67
第一節 大豆發酵乳與豆漿之組成 67
第二節 大豆發酵乳為共生質飲品 70
第三節 飲用大豆發酵乳與豆漿後對糞便菌叢之影響 72
第四節 飲用六週大豆發酵乳後受試者之生理效應 75
第五節 飲用六週大豆發酵乳後對血脂之影響 76
第六節 大豆發酵乳對血液抗氧化指標之影響 79
第六章 結論 81
第七章 参考文獻 82
1. 行政院衛生署 (2002 a) 健康食品之胃腸道功能改善評估方法,台北。
2. 行政院衛生署 (2002 b) 健康食品之調節血脂功能評估方法,台北。
3. 行政院衛生署 (2002 c) 食品成分資料庫分析,台北。
4. 行政院衛生署 (2005) 九十三年台灣地區所有人口主要死因統計顯示,台北。
5. 行政院衛生署 (2005) 健康食品許可,台北。
6. 楊晴如 (2002) 活性乳酸菌飲料對成人腸道菌相之影響及雙叉桿菌抑制產氣莢膜梭菌偶氮還原酵素之研究。台灣大學食品科技研究所碩士論文,台北。
7. 王宜婕 (2004) 乳酸菌與雙叉桿菌發酵豆奶及其產品之抗氧化活性。台灣大學食品科技研究所碩士論文,台北。
8. 楊炳輝 (2000) 豆奶加工技術。食品工業月刊。32 (1) 52-59。

Abd El-Gawad IA, el-Sayed EM, Hafez SA, el-Zeini HM & Saleh FA. (2004) Inhibitory effect of yoghurt and soya yoghurt containing bifidobacteria on the proliferation of Ehrlich ascites tumour cells in vitro and in vivo in a mouse tumour model. Br J Nutr 92(1):81-6.

Abrescia P & Golino P. (2005) Free radicals and antioxidants in cardiovascular diseases. Expert Rev Cardiovasc Ther 3(1):159-71.

Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N & Williams JK. (2002) The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vasc Biol 22(11):1859-64.

Aebi H. (1984) Catalase in vitro. Methods Enzymol 105:121-26.

Anderson JW, Johnstone BM & Cook-Newell ME. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-82.

Anderson JB & Garner SC. (2000) The soybean as a source of bioactive molecules. In: Schmidl MK, Labuza TP, eds. Essentials of Functional Foods. Gaithersburg, Maryland: Aspen Publishers:239-70.

Beaglehole R. (1990) International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev 12:1-15.

Bennet R, Nord CE & Zetterstrom R. (1992) Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli. Acta Paediatr 81:784-87.

Berrada N, Lemeland JF, Laroche G, Thouvenot P & Piaia M. (1991) Bifidobacterium from fermented milks: survival during gastric transit. J Dairy Sci 74:409-13.

Bisping B, Hering L, Baumann U, Denter J, Keuth S & Rehm HJ. (1993) Tempe fermentation: some aspects of formation of gamma-linolenic acid, proteases and vitamins. Biotechnol Adv 11(3):481-93.
Buddington RK, Williams CH, Chen SC & Witherly SA. (1996) Dietary supplementation of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63:709-16.

Buettner GR. (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 300(2):535-43.

Cassidy A, Hansley B & Lamuela-Raventos RM. (2000) Isoflavones, lignans and stilbenes-origins, metabolism and potential importance to human health. J Sci Food Agric 80:1044-62.

Charteris WP, Kelly PM, Morelli L & Collins JK. (1998) Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiology 84:759-68.

Chen GJ & Russell JB. (1988) Fermentation of peptides and amino acids by a monensin-sensitive ruminal Peptostreptococcus. Appl Environ Microbiol 54(11):2742-49.

Chen RM, Wu JJ, Lee SC, Huang AH & Wu HM. (1999) Increase of intestinal Bifidobacterium and suppression of coliform bacteria with short-term yogurt ingestion. J Dairy Sci 82(11):2308-14.

Chou LS & Weimer B. (1999) Isolation and Characterization of Acid and Bile-Tolerant Isolates from Strains of Lactobacillius acidophilus. J Dairy Sci 82:23-31.

Collins MD & Gibson GR. (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69(5):1052S-1057S.

Coward L, Smith M, Kirk M & Barnes S. (1998) Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 68 (S):1486S-91S.

Damasceno NR, Gidlund MA, Goto H, Dias CT, Okawabata FS & Abdalla DS. (2001) Casein and soy protein isolate in experimental atherosclerosis: influence on hyperlipidemia and lipoprotein oxidation. Ann Nutr Metab 45(1):38-46.

Davis JG., Ashton TR & Mccaskill M. (1971) Enumeration and viablity of L. bulgaricus and Str. Thermophilus in yogurts. Dairy Ind 36:569-73.

Desroches S, Mauger JF, Ausman LM, Lichtenstein AH & Lamarche B. (2004) Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic men and women. J Nutr 134(3):574-79.

De Boever P, Deplancke B & Verstraete W (2000) Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J Nutr 130(10):2599-606.

De Boever P, Wouters R & Verstraete W. (2001) Combined use of Lactobacillus reuteri and soygerm powder as food supplement. Lett Appl Microbiol 33(6):420-24.

Drasar B & Barrow P. (1985) Intestinal microbiology. Berkshire, England: Van Nostrand Reinhold (UK) Co. Ltd.

Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F & Collins JK. (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73(2S):386S-92S.

Duvall WL. (2005) Endothelial dysfunction and antioxidants. Mt Sinai J Med. 72(2):71-80.

Erdman, JW. (2000) Soy Protein and Cardiovascular Disease: A Statement for Healthcare Professionals From the Nutrition Committee of the AHA. Circulation 102:2555-59.

Food and Drug Administration. (1991) Department of Health claim for food. Fed Reg 56:60537-66.

FDA. 1998. Clostridium perfringens. In “Bacteriological Analytical Manual”. 8th edition, Chap. 16. U.S. Food and Drug Administration. Washington, DC.

Food and Drug Administration. (1999) Food labeling, health claims, soy protein, and coronary heart disease. Fed Reg 57:699-733.

Franke AA, Custer LJ, Wang W & Shi CY. (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217(3):263-73.

Friedewald WT, Levy RI & Fredrickson DS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499-502.
Fukushima M, Yamada A, Endo T & Nakano M. (1999) Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on delta6-desaturase activity in the livers of rats fed a fat- and cholesterol-enriched diet. Nutrition 15(5):373-8.

Fuller R.(1989) A review: probiotics in man and animals. J Appl Bacteriol 66:365-78.

Fuller R, Ed. (1992) Probiotics: the scientific basis. London: Chapman & Hall.

Gardner CD, Newell KA, Cherin R & Haskell WL. (2001) The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 73(4):728-35.

Gawel S, Wardas M, Niedworok E & Wardas P. (2004) Malondialdehyde (MDA) as a lipid peroxidation marker.Wiad Lek 57(9-10):453-5.

Gibson GR & Fuller R. (2000) Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 130 (2S):391S-95S.

Gibson GR & Roberfroid MB. (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401-12.

Gibson GR, Beatty EB, Wang X & Cummings JH. (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterol 108:975-82.
Griesmacher A,Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G & Mueller M. (1995) Enhanced serum levels of thiobarbituric acid-reactive substances in diabetes mellitus. Am J Med 98: 469-75.

Gorbach SL & Goldin BR. (1992) Nutrition and the gastrointestinal microflora. Nutr Rev 50(12):378-81.

Goldin BR. (1990) Intestinal microflora: metabolism of drugs and carcinogens. Ann Med 22(1):43-8.

Gutteridge JM & Halliwell B. (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 15(4):129-35.

Hoey L, Rowland IR, Lloyd AS, Clarke DB & Wiseman H. (2004) Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 91(4):607-16.

Isolauri E, Juntunen M, Rautanen T, Sillanaukee P & Koivula T. (1991) A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88:90-7.

Iwai K, Nakaya N, Kawasaki Y & Matsue H. (2002a) Inhibitory effect of natto, a kind of fermented soybeans, on LDL oxidation in vitro. J Agric Food Chem 50(12):3592-96.

Iwai K, Nakaya N, Kawasaki Y & Matsue H. (2002b) Antioxidative functions of natto, a kind of fermented soybeans: effect on LDL oxidation and lipid metabolism in cholesterol-fed rats. J Agric Food Chem 50(12):3597-601.

Jarvinen R, Knekt P, Hakulinen T, Rissanen H & Heliovaara M. (2001) Dietary fat, cholesterol and colorectal cancer in a prospective study. Br J Cancer 85(3):357-61.

Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA & Josse RG. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76(2):365-72.

Kaloud H & Stogmann W. (1969) Clinical experience with a bifidus milk feed. Arch Kinderheilkd 177:29-35.

Kano M, Ishikawa F, Matsubara S, Kikuchi-Hayakawa H & Shimakawa Y. (2002) Soymilk products affect ethanol absorption and metabolism in rat during acute and chronic ethanol intake. J Nutr 132: 238-244.

Kasper H. (1998) Protection against gastrointestinal diseases-present facts and future developments. Int J Food Microbiol 41(2):127-31.

Kim DH, Jung EA, Sohng IS, Han JA, Kim TH & Han MJ. (1998) Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 21:17-23.

Klaver FA & van der Meer R. (1993) The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol 59(4):1120-4.

Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson JA. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139(10):4252-63.

Kurmann JA & Rasic JL. (1991) The health potential of products containing bifidobacteria. In: Robinson, R.K. (Ed.), Therapeutic of Fermented Milks. Appl Food Sci. Elsevier, London p117-58.

Lankaputhra WEV & Shah N P. (1995) Survival of Lactobacillus acidophilus and Bifidobacterium spp in the presence of acid and bile salts. Cult Dairy Prod J 30:2-7.

Langhendries JP, Detry J & Van Hees J. (1995) Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr. 21:177-81.

LeBlanc JG, Silvestroni A, Connes C, Juillard V, de Giori GS, Piard JC & Sesma F. (2004) Reduction of non-digestible oligosaccharides in soymilk: application of engineered lactic acid bacteria that produce alpha-galactosidase. Genet Mol Res 3(3):432-40.

Lin MY & Yen CL (1999) Antioxidative ability of lactic acid bacteria. J Agric Food Chem 47(4):1460-6.

Liu C, Liu Y & Chen S. (2005) Effects of nutrient supplements on simultaneous fermentation of nisin and lactic acid from cull potatoes. Appl Biochem Biotechnol 121-124:475-83.

Lowry OH, Rosebrough NJ, Farr AL & Randall RJ. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-75.
Lovati MR, Manzoni C, Corsini A, Granata A, Frattini R, Fumagalli R & Sirtori CR. (1992) Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. J Nutr 122(10):1971-8.

Macgillivray PC, Finlay HVL & Binns TB. (1959) Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants. Scott Med J 4(4):182-89.

Manzoni C, Duranti M, Eberini I, Scharnag H, Marz W, Castiglioni S & Lovati MR. (2003) Subcellular localization of soybean 7S globulin in HepG2 cells and LDL receptor up-regulation by its alpha' constituent subunit. J Nutr 133(7):2149-55.

Maruyama N, Katsube T, Wada Y, Oh MH, Barba De La Rosa AP, Okuda E, Nakagawa S & Utsumi S. (1998) The roles of the N-linked glycans and extension regions of soybean beta-conglycinin in folding, assembly and structural features.Eur J Biochem 258(2):854-62.

Maruyama N, Sato R, Wada Y, Matsumura Y, Goto H, Okuda E, Nakagawa S, Utsumi S. (1999) Structure-physicochemical function relationships of soybean beta-conglycinin constituent subunits. J Agric Food Chem 47(12):5278-84.

Messina M, Messina V & Setchell K. (1994) The Simple Soybean and Your Health. Garden City Park, NY: Avery Publishing Group.

Metges CC. (2000) Contribution of microbial amino acids to amino acid homeostasis of the host. J Nutr 130(7):1857-64S.

Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA & Shay N. (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133(5):1238-43.

Moncada S, Palmer RMJ & Higgs EA. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.

Muñoa FJ & Pares R. (1988) Selective medium for isolation and enumeration of Bifidobacterium spp. Appl Environ Microbiol 54: 1715-18.

Murphy MP, Packer MA, Scarlett JL & Martin SW. (1998) Peroxynitrite: a biologically significant oxidant. Gen Pharmacol (2):179-86.

Murti TW, Bouillanne C, Landon M & Desmazeaud MJ. (1993a) Bacterial growth and volatile compounds in yoghurt type products from soymilk containing Bifidobacterium ssp. J. Food Sci 58:153- 157.

Nagata C, Takatsuka N, Kurisu Y & Shimizu H. (1998) Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 128(2):209-13.
Nishi T, Hara H, Asano K & Tomita F. (2003) The soybean beta-conglycinin beta 51-63 fragment suppresses appetite by stimulating cholecystokinin release in rats. J Nutr 133(8):2537-42.

Rasic JL & Kurmann JA. (1978) Yoghurt. Scientific Grounds, Technology, Manufacture and Preparations, first ed. Technical Dairy Publishing House, Copenhagen.

Reinli K & Block G. (1996) Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 26:123-48.

Rowland IR & Tanaka R. (1993) The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 74:667-74.

Rowland I, Wiseman H, Sanders T, Adlercreutz H & Bowey E. (1999) Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 27(2):304-8.

Scalbert A & Williamson G. (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073-85S.

Scalabrini P, Rossi M, Spettoli P & Matteuzzi D. (1998) Characterization of Bifidobacterium strain for use in soymilk fermentation. Int J Food Microbiol 39: 213-19.

Setchell KD. (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68(6S):1333S-46S.

Setchell KD, Zimmer-Nechemias L, Cai J & Heubi JE. (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350(9070):23-27.

Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A & Heubi JE. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131(4 S):1362-75S.

Slominski BA. (1994) Hydrolysis of galactooligosaccharides by commercial preparations of alpha-galactosidase and beta-fructofuranose: Potential for use as dietary additives. J Sci Food Agric 65:323-30.

Sugano M, Goto S, Yamada Y, Yoshida K, Hashimoto Y, Matsuo T & Kimoto M. (1990) Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J Nutr 120(9):977-85.

Shah NP & Jelen P. (1990) Survival of lactic acid bacteria and their lactases under acidic conditions. J. Food Sci 55:506-09.

Shah NP. (2000) Probiotic bacteria: Selective enumeration and survival in dairy foods. J Dairy Sci 83:894-907.
Shimakawa Y, Matsubara S, Yuki N, Ikeda M & shikawa F. (2003) Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. International Journal of Food Microbiology 81: 131-36.

Simon GL, Gorbach SL. (1984) Intestinal flora in health and disease. Gastroenterology 86(1):174-93.

Smiricky-Tjardes MR, Flickinger EA, Grieshop CM, Bauer LL, Murphy MR & Fahey GC Jr. (2003) In vitro fermentation characteristics of selected oligosaccharides by swine fecal microflora. J Anim Sci 81(10):2505-14.

Slominski BA. (1994) Hydrolysis of galactooligosaccharides by commercial preparations of alpha-galactosidase and beta-fructofuranose: Potential for use as dietary additives. J Sci Food Agric 65: 323-30.

Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N & Shimizu H. (2000) Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 31(4):308-14.

Tanaka R & Mutai M. (1980) Improved medium for selective isolation and enumeration of Bifidobacterium. Appl Environ Microbiol 40:866-69.

Tamir S & Tannenbaum SR. (1996) The role of nitric oxide (NO.) in the carcinogenic process. Biochim Biophys Acta 1288(2): F31-6.

Tharmaraj N & Shah NP. (2003) Selective enumeration of Lactobacillus delbrueckii ssp. bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, bifidobacteria, Lactobacillus casei, Lactobacillus rhamnosus, and propionibacteria. J Dairy Sci 86(7):2288-96.

Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. (1998) Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 95:3106-10.

Wang MF, Yamamoto S, Chung HM, Chung SY, Miyatani S, Mori M, Okita T & Sugano M. (1995) Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J Nutr Sci Vitaminol (Tokyo) 41(2):187-95.

Wang YC, Yu RC & Chou CC. (2002) Growth and survival of bifidobacteria and lactic acid bacteria during the fermentation and storage of cultured soymilk drink. Food Microbiology 19:501-08.

Wang YC, Yu RC, Yang HY & Chou CC. (2003) Sugar and acid contents in soymilk fermented with lactic acid bacteria alone or simultaneously with bifidobacteria. Food Microbiology 20:333-38.

Wang H & Murphy PA. (1994) Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-73.

Wangen KE, Duncan AM, Xu X & Kurzer MS. (2001) Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73(2):225-31.

Wiseman H. (1999) The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens. Proc Nutr Soc 58(1):139-46.

Wiseman H, Casey K, Bowey EA, Duffy R, Davies M, Rowland IR, Lloyd AS, Murray A, Thompson R & Clarke DB. (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80(3):692-99.

Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR & Sanders TA. (2000) Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72(2):395-400.

Williams PT, Superko HR, Haskell WL, Alderman EL, Blanche PJ, Holl LG & Krauss RM. (2003) Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23(2):314-21.

Xiao CW, L'Abbe MR, Gilani GS, Cooke GM, Curran IH & Papademetriou SA. (2004) Dietary soy protein isolate and isoflavones modulate hepatic thyroid hormone receptors in rats. J Nutr 134(4):743-49.

Xu X, Harris KS,Wang HJ, Murphy PA & Hendrich S. (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125:2307-15.

Yen GC & Lai HH. (2003) Inhibition of reactive nitrogen species effects in vitro and in vivo by isoflavones and soy-based food extracts. J Agric Food Chem 51(27):7892-900.

Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S & Kris-Etherton PM (1999) Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69 (4): 632-46.

Yokota A, Veenstra M, Kurdi P, van-Veen HW & Konings WN. (2000) Cholate resistance in Lactococcus lactis is mediated by an ATP-dependent multispecific organic anion transporter. J Bacteriol 182: 5196–5201.

Young IS & Woodside JV. (2001) Antioxidants in health and disease. J Clin Pathol 54(3):176-86.

USB, the united soybean board. (2004) Soyfoods guide.www.soybean.org.

Zhuo XG, Melby MK & Watanabe S (2004) Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr 134(9):2395-400.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top